Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress

Heart Surgery Forum

Volumn 12, Issue 1, 2009, Pages

  Rodrigues, Alfredo J ^a   Évora, Paulo R B ^a   Bassetto, Solange ^a   Alves Jr , Lafaiete ^a   Scorzoni Filho, Adilson ^a   Origuela, Eliana A ^a   Vicente, Walter V A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; CARDIOPLEGIC AGENT; MALONALDEHYDE; TROPONIN I; VASCULAR CELL ADHESION MOLECULE 1; SCAVENGER;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY HEMODYNAMICS; CORONARY SINUS; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HEMODYNAMICS; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART ARREST; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCYSTEINE; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; FREE RADICAL SCAVENGERS; HEART ARREST, INDUCED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 66649086957     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20081134     Document Type: Article

References (20)

1. Aruoma OI, Halliwell B, Hoey BM, et al. 1989. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6:593-7.
2. Boldt J, Kumle B, Papsdorf M, et al. 1998. Are circulating adhesion molecules specifically changed in cardiac surgical patients? Ann Thorac Surg 65:608-14.
3. Cakir O, Oruc A, Kaya S, et al. 2004. N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest. J Card Surg 19:221-5.
4. Cotgreave IA. 1997. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 38 205-27.
5. Croal BL, Hillis GS, Gibson PH, et al. 2006 Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114:1468-75.
6. Cuzzocrea S, Mazzon E, Costantino G, et al. 2000. Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 47:537-48.
7. Fischer UM, Cox CS Jr, Allen SJ, et al. 2003. The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. J Thorac Cardiovasc Surg 126:1483-8.
8. Fischer UM, Tossios P, Huebner A, et al. 2004. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 128:103-8.
9. Groeneveld AB, Sipkema P. 2000. Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis. Crit Care Med 28:2161-2.
10. Koramaz I, Pulathan Z, Usta S, et al. 2006. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Ann Thorac Surg 81:613-8.
11. Laude K, Thuillez C, Richard V. 2001. Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target? Braz J Med Biol Res 34:1-7.
12. Moukarbel GV, Ayoub CM, Abchee AB. 2004. Pharmacological therapy for myocardial reperfusion injury. Curr Opin Pharmacol 4:147-53.
13. Nesher N, Alghamdi AA, Singh SK, et al. 2008. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg 85:1348-54.
14. Papaharalambus CA, Griendling KK. 2007. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17:48-54.
15. Postadzhiyan AS, Tzontcheva AV, Kehayov I, et al. 2008. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem 41:126-33.
16. Rodrigues AJ, Evora PR, Schaff HV. 2004. Protective effect of N-acetylcysteine against oxygen radical-mediated coronary artery injury. Braz J Med Biol Res 37:1215-24.
17. Sochman J, Vrbska J, Musilova B, et al. 1996. Infarct size limitation: acute N-acetylcysteine defense (ISLAND trial): preliminary analysis and report after the first 30 patients. Clin Cardiol 19:94-100.
18. van Klaveren RJ, Dinsdale D, Pype JL, et al. 1997. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. Am J Physiol 273:L548-55.
19. Vento AE, Nemlander A, Aittomaki J, et al. 2003. N-acetylcysteine as an additive to crystalloid cardioplegia increased oxidative stress capacity in CABG patients. Scand Cardiovasc J 37:349-55.
20. Zafarullah M, Li WQ, Sylvester J, et al. 2003. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6-20.